NOT a recurrence, but resistance, please don't mislead

same as Tarceva (erlotinib). The therapeutic effects of CO-1686, or AZD-9291 will also wear off as patient's cancer becomes resistant in a matter of months.  

Your post should be categorized as ADVERTISEMENT and moved to appropriate page in WXC.